guest ::
| Home > Publications database > Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage. > print |
| Home > Publications database > Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage. > print |
| 001 | 127165 | ||
| 005 | 20240228140908.0 | ||
| 024 | 7 | _ | |a 10.15252/emmm.201404246 |2 doi |
| 024 | 7 | _ | |a pmid:25680861 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC4364949 |2 pmc |
| 024 | 7 | _ | |a 1757-4676 |2 ISSN |
| 024 | 7 | _ | |a 1757-4684 |2 ISSN |
| 024 | 7 | _ | |a altmetric:3606026 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2017-03191 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Mogler, Carolin |0 P:(DE-He78)18e5b355e4a312d2065b1ae2a9d47654 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage. |
| 260 | _ | _ | |a Weinheim |c 2015 |b Wiley-VCH |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1508308312_2851 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Liver fibrosis is a reversible wound-healing response to injury reflecting the critical balance between liver repair and scar formation. Chronic damage leads to progressive substitution of liver parenchyma by scar tissue and ultimately results in liver cirrhosis. Stromal cells (hepatic stellate cells [HSC] and endothelial cells) have been proposed to control the balance between liver fibrosis and regeneration. Here, we show that endosialin, a C-type lectin, expressed in the liver exclusively by HSC and portal fibroblasts, is upregulated in liver fibrosis in mouse and man. Chronic chemically induced liver damage resulted in reduced fibrosis and enhanced hepatocyte proliferation in endosialin-deficient (EN(KO)) mice. Correspondingly, acute-liver-damage-induced hepatocyte proliferation (partial hepatectomy) was increased in EN(KO) mice. A candidate-based screen of known regulators of hepatocyte proliferation identified insulin-like growth factor 2 (IGF2) as selectively endosialin-dependent hepatocyte mitogen. Collectively, the study establishes a critical role of HSC in the reciprocal regulation of fibrogenesis vs. hepatocyte proliferation and identifies endosialin as a therapeutic target in non-neoplastic settings. |
| 536 | _ | _ | |a 311 - Signalling pathways, cell and tumor biology (POF3-311) |0 G:(DE-HGF)POF3-311 |c POF3-311 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Antigens, CD |2 NLM Chemicals |
| 650 | _ | 7 | |a Antigens, Neoplasm |2 NLM Chemicals |
| 650 | _ | 7 | |a CD248 protein, human |2 NLM Chemicals |
| 650 | _ | 7 | |a Neoplasm Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a tumor endothelial marker 1, mouse |2 NLM Chemicals |
| 700 | 1 | _ | |a Wieland, Matthias |0 P:(DE-He78)0792aae05ea250d2937cdfa6c9ca05fc |b 1 |u dkfz |
| 700 | 1 | _ | |a König, Courtney |0 P:(DE-He78)5ef958977fa3c0658679b496419ce762 |b 2 |u dkfz |
| 700 | 1 | _ | |a Hu, Junhao |b 3 |
| 700 | 1 | _ | |a Runge, Anja |0 P:(DE-He78)cc84101e4a6f5a7a41c9012f423dbd0f |b 4 |u dkfz |
| 700 | 1 | _ | |a Korn, Claudia |0 P:(DE-He78)9f5445b47d46f5f026560c307119a7da |b 5 |u dkfz |
| 700 | 1 | _ | |a Besemfelder, Eva |0 P:(DE-He78)9be9200416a88a73cc9c25339b19b58f |b 6 |u dkfz |
| 700 | 1 | _ | |a Breitkopf-Heinlein, Katja |b 7 |
| 700 | 1 | _ | |a Komljenovic, Dorde |0 P:(DE-He78)30816ab8532422ad8d4a8af55bc0d24b |b 8 |u dkfz |
| 700 | 1 | _ | |a Dooley, Steven |b 9 |
| 700 | 1 | _ | |a Schirmacher, Peter |b 10 |
| 700 | 1 | _ | |a Longerich, Thomas |b 11 |
| 700 | 1 | _ | |a Augustin, Hellmut |0 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b |b 12 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.15252/emmm.201404246 |g Vol. 7, no. 3, p. 332 - 338 |0 PERI:(DE-600)2485479-7 |n 3 |p 332 - 338 |t EMBO molecular medicine |v 7 |y 2015 |x 1757-4684 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:127165 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)18e5b355e4a312d2065b1ae2a9d47654 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)0792aae05ea250d2937cdfa6c9ca05fc |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)5ef958977fa3c0658679b496419ce762 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)cc84101e4a6f5a7a41c9012f423dbd0f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)9f5445b47d46f5f026560c307119a7da |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)9be9200416a88a73cc9c25339b19b58f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)30816ab8532422ad8d4a8af55bc0d24b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-311 |2 G:(DE-HGF)POF3-300 |v Signalling pathways, cell and tumor biology |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EMBO MOL MED : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EMBO MOL MED : 2015 |
| 920 | 1 | _ | |0 I:(DE-He78)A190-20160331 |k A190 |l Vaskuläre Onkologie und Metastasierung |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)E020-20160331 |k E020 |l Medizinische Physik in der Radiologie |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A190-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L101-20160331 |
| 980 | _ | _ | |a I:(DE-He78)E020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|